Amy Stark to Antimetabolites, Antineoplastic
This is a "connection" page, showing publications Amy Stark has written about Antimetabolites, Antineoplastic.
Connection Strength
0.187
-
Comprehensive genetic analysis of cytarabine sensitivity in a cell-based model identifies polymorphisms associated with outcome in AML patients. Blood. 2013 May 23; 121(21):4366-76.
Score: 0.097
-
Identification of novel germline polymorphisms governing capecitabine sensitivity. Cancer. 2012 Aug 15; 118(16):4063-73.
Score: 0.089